Berger Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Hold |
10,929
| – | – | ﹤0.01% | 415 |
|
|
2025
Q1 | $5.04K | Hold |
10,929
| – | – | ﹤0.01% | 413 |
|
|
2024
Q4 | $8.07K | Hold |
10,929
| – | – | ﹤0.01% | 409 |
|
|
2024
Q3 | $17.2K | Hold |
10,929
| – | – | ﹤0.01% | 390 |
|
|
2024
Q2 | $18.4K | Hold |
10,929
| – | – | ﹤0.01% | 362 |
|
|
2024
Q1 | $26.2K | Hold |
10,929
| – | – | ﹤0.01% | 360 |
|
|
2023
Q4 | $16.7K | Hold |
10,929
| – | – | ﹤0.01% | 305 |
|
|
2023
Q3 | $11.9K | Hold |
10,929
| – | – | ﹤0.01% | 276 |
|
|
2023
Q2 | $25K | Hold |
10,929
| – | – | ﹤0.01% | 286 |
|
|
2023
Q1 | $26.6K | Hold |
10,929
| – | – | ﹤0.01% | 266 |
|
|
2022
Q4 | $20.9K | Hold |
10,929
| – | – | ﹤0.01% | 257 |
|
|
2022
Q3 | $26K | Hold |
10,929
| – | – | ﹤0.01% | 233 |
|
|
2022
Q2 | $20K | Hold |
10,929
| – | – | ﹤0.01% | 242 |
|
|
2022
Q1 | $23K | Buy |
+10,929
| New | +$23K | ﹤0.01% | 267 |
|